Cargando…
The Anticancer Effects of Novel Imidazo[1,2-a]Pyridine Compounds against HCC1937 Breast Cancer Cells
BACKGROUND: Anticancer drugs confront clinical obstacles such as drug resistance and adverse effects. Imidazo[1,2-a]pyridines (IPs) compounds have lately gained considerable interest as possible anticancer therapeutics due to their potent inhibitory function against cancers cells. This study was to...
Autores principales: | Altaher, Akram M, Adris, Mohammed A, Aliwaini, Saeb H, Awadallah, Adel M, Morjan, Rami Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810306/ https://www.ncbi.nlm.nih.gov/pubmed/36172656 http://dx.doi.org/10.31557/APJCP.2022.23.9.2943 |
Ejemplares similares
-
Novel imidazo[1,2-a]pyridine inhibits AKT/mTOR pathway and induces cell cycle arrest and apoptosis in melanoma and cervical cancer cells
por: Aliwaini, Saeb, et al.
Publicado: (2019) -
Crystal structures of pure 3-(4-bromo-2-chlorophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one and contaminated with 3-(4-bromophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one
por: Wahedy, Kanan, et al.
Publicado: (2017) -
6-Bromoimidazo[1,2-a]pyridin-8-amine
por: Dahmani, Siham, et al.
Publicado: (2011) -
2-Phenylimidazo[1,2-a]pyridine-3-carbaldehyde
por: Anaflous, Abderrahman, et al.
Publicado: (2008) -
Crystal structure of (5-methylimidazo[1,2-a]pyridin-2-yl)methanol
por: Elaatiaoui, Abdelmalik, et al.
Publicado: (2014)